Abstract: A method for treating cancer and/or preventing or reducing metastasis or treating angiogenesis related disorders comprising the step of administering IL-31 or peptide which is at least about 70%, homologous to the IL-31 sequence as set forth in SEQ ID No. 1.
Type:
Application
Filed:
March 26, 2018
Publication date:
October 18, 2018
Applicant:
Rappaport Familly Institute For Research
Inventors:
Ella FREMDER, Ami Aronheim, Yuval Shaked